NextCure, Inc.
NXTC · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$8,624 | -$26,808 | -$10,976 | -$11,603 |
| Dep. & Amort. | $533 | $247 | $654 | $674 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $600 | $588 | $1,363 | $1,519 |
| Change in WC | $1,121 | $2,877 | -$3,940 | $2,585 |
| Other Non-Cash | $102 | $383 | -$95 | -$144 |
| Operating Cash Flow | -$6,268 | -$22,713 | -$12,994 | -$6,969 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $34 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | -$12,736 | -$13,969 | -$8,339 |
| Inv. Sales/Matur. | $8,700 | $16,495 | $21,063 | $15,263 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $8,700 | $3,759 | $7,094 | $6,958 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $2,019 | $0 | $36 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $0 |
| Financing Cash Flow | $0 | $2,019 | $0 | $36 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $2,432 | -$16,935 | -$5,900 | $25 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $4,892 | $21,827 | $27,727 | $27,702 |
| End Cash | $7,324 | $4,892 | $21,827 | $27,727 |
| Free Cash Flow | -$6,268 | -$22,713 | -$12,994 | -$6,935 |